Precigen, Inc.
PGEN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $1 | $1 | $1 |
| % Growth | 241.4% | -36.2% | 12.7% | – |
| Cost of Goods Sold | $1 | $2 | $1 | $1 |
| Gross Profit | $2 | -$1 | $0 | $0 |
| % Margin | 64.6% | -81.7% | 18% | 1.8% |
| R&D Expenses | $12 | $11 | $10 | $12 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $24 | $0 | $12 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $20 | $0 | $6 |
| Operating Expenses | $36 | $31 | $23 | $29 |
| Operating Income | -$34 | -$32 | -$23 | -$29 |
| % Margin | -1,180% | -3,710.7% | -1,685% | -2,396.3% |
| Other Income/Exp. Net | -$112 | $5 | -$32 | $9 |
| Pre-Tax Income | -$146 | -$27 | -$54 | -$20 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$146 | -$27 | -$54 | -$20 |
| % Margin | -5,008.4% | -3,112.4% | -4,038.3% | -1,657.7% |
| EPS | -1.1 | -0.09 | -0.18 | -0.067 |
| % Growth | -1,123.6% | 50.1% | -167.1% | – |
| EPS Diluted | -1.1 | -0.09 | -0.18 | -0.067 |
| Weighted Avg Shares Out | 296 | 296 | 294 | 293 |
| Weighted Avg Shares Out Dil | 296 | 296 | 294 | 293 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$145 | -$27 | -$54 | -$19 |
| % Margin | -4,950% | -3,180.7% | -3,991.3% | -1,609.5% |